Tg Therapeutics TGTX
NASDAQ TGTX
$54.71 -1.07 (-1.91%)
As of: Oct 1, 2026 · 11:34 AM EDT

Tg Therapeutics (TGTX) Deferred Taxes (2025 - 2026)

Updated

Tg Therapeutics' Deferred Taxes was $708,000 in Q2 2026, down 81.7% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Deferred Taxes (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tg Therapeutics' Deferred Taxes was -$343.43 million through Jun 30, 2026; for FY2025, it was -$348 million.

  • Quarterly Deferred Taxes has moved between -$366.63 million (Q3 2025) and $18.63 million (Q4 2025) over five years.
  • Per Business Quant data, TGTX's Deferred Taxes in the three quarters before Q2 2026 was $3.86 million (Q1 2026), $18.63 million (Q4 2025) and -$366.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -479.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -195.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -587.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn 708,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 708,000.00
Mar 31, 2026 3.86 Mn
Dec 31, 2025 18.63 Mn
Sep 30, 2025 -366.63 Mn
API Access

Tg Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=TGTX&period=max&api_key=YOUR_API_KEY